BBI
ARRY

Baxter Bros Inc’s Array Biopharma Inc ARRY Stock Holding History

Baxter Bros Inc’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,200
Closed -$145K – 110
2018
Q4 		$145K Hold
10,200
– – 0.04% 106
2018
Q3 		$155K Hold
10,200
– – 0.04% 110
2018
Q2 		$171K Hold
10,200
– – 0.05% 110
2018
Q1 		$166K Sell
10,200
-4,000
-28% -$64.1K 0.05% 113
2017
Q4 		$182K Hold
14,200
– – 0.05% 116
2017
Q3 		$175K Hold
14,200
– – 0.05% 116
2017
Q2 		$119K Hold
14,200
– – 0.04% 113
2017
Q1 		$127K Sell
14,200
-20,000
-58% -$213K 0.04% 110
2016
Q4 		$301K Sell
34,200
-3,000
-8% -$22.1K 0.1% 96
2016
Q3 		$251K Hold
37,200
– – 0.08% 101
2016
Q2 		$132K Buy
+37,200
New +$121K 0.05% 103
2015
Q4 		$149K Hold
35,200
– – 0.06% 109
2015
Q3 		$254K Hold
35,200
– – 0.09% 102
2015
Q2 		$254K Hold
35,200
– – 0.09% 103
2015
Q1 		$259K Sell
35,200
-10,000
-22% -$71.2K 0.09% 98
2014
Q4 		$214K Buy
45,200
+19,000
+73% +$75.1K 0.08% 107
2014
Q3 		$94K Hold
26,200
– – 0.04% 113
2014
Q2 		$119K Buy
26,200
+5,200
+25% +$21.5K 0.05% 105
2014
Q1 		$99K Hold
21,000
– – 0.04% 97
2013
Q4 		$105K Hold
21,000
– – 0.05% 95
2013
Q3 		$131K Hold
21,000
– – 0.07% 85
2013
Q2 		$95K Buy
+21,000
New +$113K 0.06% 79

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Baxter Bros Inc's ARRY Position: Q1 2019 in Review

Baxter Bros Inc sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 10,200 shares — an estimated $145K sold.

Baxter Bros Inc first reported a position in ARRY in Q2 2013 and held it in 22 quarters. The position peaked at $301K in Q4 2016. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Baxter Bros Inc reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • Baxter Bros Inc sold 10,200 Array Biopharma Inc shares in Q1 2019, an estimated $145K.
  • Baxter Bros Inc first reported a position in Array Biopharma Inc in Q2 2013 and held it in 22 quarters.
  • Baxter Bros Inc's Array Biopharma Inc position peaked at $301K in Q4 2016.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Baxter Bros Inc's 13F filing for Q1 2019, filed 22 Apr 2019.